Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Zhejiang University
Clinique Paris-Bercy
UNICANCER
Northwestern University
OHSU Knight Cancer Institute
Sorlandet Hospital HF
University of Minnesota
Memorial University of Newfoundland
Alaska Native Tribal Health Consortium
VA Office of Research and Development
Emory University
Dartmouth-Hitchcock Medical Center
Chinese University of Hong Kong
Uppsala University Hospital
University of California, San Diego
Hospital Clinic of Barcelona
Hospital Universitario de Móstoles
Asociación Española de GastroenterologÃa
Jubaan Ltd.
Odin Medical
State Scientific Centre of Coloproctology, Russian Federation
National Taiwan University Hospital
Egymedicalpedia
Columbia University
Rush University Medical Center
Istanbul Medipol University Hospital
Mayo Clinic
University of Tabuk
Hospital Provincial de Castellon
Parc de Salut Mar
Washington University School of Medicine
Saneso Inc.
Instituto Ecuatoriano de Enfermedades Digestivas
Instituto Ecuatoriano de Enfermedades Digestivas
Gastroenterologie Baden-Wettingen
American College of Radiology Imaging Network
Hospital Universitario de Canarias
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Deventer Ziekenhuis
University of Warmia and Mazury in Olsztyn
Assistance Publique - Hôpitaux de Paris
Indiana University
IHU Strasbourg
Indiana University
University of Pennsylvania